You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic Hepatitis C Virus

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-493, ABT-530, ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C
  • Hepatitis C Virus
  • (no location specified)
Jul 9, 2021

Hepatitis C, Chronic, Opioid-use Disorder Trial in Pittsburgh (Sofosbuvir/Velpatasvir)

Completed
  • Hepatitis C, Chronic
  • Opioid-use Disorder
  • Pittsburgh, Pennsylvania
    Magee Womens Hospital of UPMC
Aug 19, 2022

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

De Novo Autoimmune Hepatitis in Pediatric Liver Transplantation

Terminated
  • De Novo Autoimmune Hepatitis
  • Pediatric transplant subject with d-AIH
  • +6 more
  • (no location specified)
Dec 9, 2021

Hepatitis C, Chronic Trial in Pittsburgh (Sofosbuvir-Velpatasvir Drug Combination)

Recruiting
  • Hepatitis C, Chronic
  • Sofosbuvir-Velpatasvir Drug Combination
  • Pittsburgh, Pennsylvania
    University of Pittsburgh, Magee Womens Hospital
Sep 3, 2021

Hepatitis C Virus Trial (ABT-450/r/ABT-267, Ribavirin)

Completed
Has Results
  • Hepatitis C Virus
  • (no location specified)
Jul 28, 2021

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Hepatitis C, Chronic, Substance Use Disorders Trial in Roanoke (Peer specialist (PS) and vouchers)

Not yet recruiting
  • Hepatitis C, Chronic
  • Substance Use Disorders
  • Peer specialist (PS) and vouchers
  • Roanoke, Virginia
    Carilion Clinic
May 25, 2022

Hepatitis B Trial in Worldwide (JNJ-73763989, JNJ-56136379, Entecavir (ETV))

Active, not recruiting
  • Hepatitis B
  • Baltimore, Maryland
  • +9 more
Jan 17, 2023

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +4 more
  • (no location specified)
Jul 29, 2021

Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil)

Terminated
  • Hepatitis B, Chronic
  • Hillsborough, New Jersey
  • +11 more
Dec 28, 2022

Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir adult formulation, Glecaprevir/pibrentasvir pediatric

Completed
Has Results
  • Hepatitis C Virus (HCV)
  • Glecaprevir/pibrentasvir adult formulation
  • Glecaprevir/pibrentasvir pediatric formulation
  • San Francisco, California
  • +37 more
Sep 19, 2022

Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
  • Phoenix, Arizona
  • +47 more
Jun 27, 2022

Glecaprevir/Pibrentasvir in Chronic Hepatitis C Genotypes 1 to 6

Completed
  • Hepatitis C Virus (HCV)
    • Makhachkala, Dagestan, Respublika, Russian Federation
    • +7 more
    Jun 23, 2022

    Possible Differences in HCC Course Depending on DAA Treatment

    Recruiting
    • Carcinoma, Hepatocellular
    • +5 more
    • Direct Acting Antivirals
    • Warsaw, Mazowieckie, Poland
      Medical University of Warsaw
    May 11, 2022

    Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis Trial (ABT-493, ABT-530, ABT-450/r/ABT-267, ABT-333)

    Completed
    Has Results
    • Chronic Hepatitis C
    • +2 more
    • (no location specified)
    Jul 8, 2021

    HCV, Hepatitis C Infection, Genotype 4 Trial (2 DAA, RBV)

    Completed
    Has Results
    • HCV
    • +2 more
    • (no location specified)
    Jul 28, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +4 more
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +2 more
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +2 more
    • (no location specified)
    Jul 8, 2021

    Hepatitis C Screening Paired With Mammography

    Recruiting
    • Hepatitis C
    • Breast Cancer
      • Montpellier, Occitanie, France
      • +3 more
      Mar 30, 2022

      Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-450/r/ABT-267, ABT-333,

      Completed
      Has Results
      • Hepatitis C Virus Infection
      • +3 more
      • (no location specified)
      Jul 8, 2021

      Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin)

      Completed
      Has Results
      • Chronic Hepatitis C Infection
      • (no location specified)
      Jul 8, 2021

      Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

      Completed
      Has Results
      • Chronic Hepatitis C Infection
      • Compensated Cirrhosis
      • ABT-450/r/ABT-267, ABT-333
      • Ribavirin (RBV)
      • (no location specified)
      Jul 8, 2021